Revisiting infant growth prior to childhood onset type 1 diabetes

A V Kharagjitsingh1, M A J de Ridder, B O Roep

  • 1Department of Paediatrics, Erasmus University Medical Centre/Sophia Children's Hospital, Rotterdam.

Clinical Endocrinology
|September 12, 2009
PubMed

Insights

Accelerated growth in the first year of life is linked to childhood type 1 diabetes (T1D) risk. Familial growth patterns influence later growth, not T1D predisposition itself.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Childhood type 1 diabetes (T1D) risk is associated with accelerated early growth.
  • Familial factors influencing growth are often unaddressed confounders in T1D research.

Purpose of the Study:

  • To investigate early growth patterns in children who develop T1D.
  • To differentiate T1D-specific growth effects from familial influences.

Main Methods:

  • A retrospective family case-control study design.
  • Utilized siblings as matched familial controls to account for shared environmental and genetic factors.
  • Analyzed weight and height data from 213 T1D patients and 255 healthy siblings up to age 4.

Main Results:

  • No significant differences in birth weight or length between T1D patients and siblings.
  • Weight standard deviation score (SDS) differed significantly in the first year (P = 0.0001).
  • Both groups exhibited parallel enhanced weight and height gain SDS after the first year; earlier T1D onset correlated with higher weight SDS at 6 months.

Conclusions:

  • The association between increased growth and T1D development is primarily confined to the first year of life.
  • Post-first year growth differences are likely attributable to familial patterns, not T1D predisposition.
  • Early-life weight gain (by 6 months) is a critical factor in the later development of T1D.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...